Impact of somatic mutations on clinical and pathologic outcomes in borderline resectable and locally advanced pancreatic cancer treated with neoadjuvant chemotherapy and stereotactic body radiotherapy followed by surgical resection

PURPOSE: The purpose of this study was to determine if somatic mutations are associated with clinical and pathologic outcomes in patients with borderline resectable pancreatic cancer (BRPC) or locally advanced pancreatic cancer (LAPC) who were treated with neoadjuvant chemotherapy and stereotactic b...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddy, Abhinav V., Hill, Colin S., Sehgal, Shuchi, Ding, Ding, Hacker-Prietz, Amy, He, Jin, Zheng, Lei, Herman, Joseph M., Meyer, Jeffrey, Narang, Amol K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743453/
https://www.ncbi.nlm.nih.gov/pubmed/34986552
http://dx.doi.org/10.3857/roj.2021.00815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743453/
https://www.ncbi.nlm.nih.gov/pubmed/34986552
http://dx.doi.org/10.3857/roj.2021.00815

Ejemplares similares